Search
- Jan 16
Jefferies analyst Michael Yee previews the year ahead, the outlook for M&A, and dives into top picks
Michael Yee shares takeaways from last week's conference in San Francisco and highlights his top names to watch.
- Aug 3, 2023
Jefferies’ Michael Yee joins BiotechTV for Analyst Thursdays
Michael Yee gives his take on biotech and discusses Vertex, Ventyx Biosciences, ALX Oncology, Akero, and Prothena.